Heartbeam Inc
NASDAQ:BEAT

Watchlist Manager
Heartbeam Inc Logo
Heartbeam Inc
NASDAQ:BEAT
Watchlist
Price: 0.9158 USD -0.46% Market Closed
Market Cap: $37.6m

Heartbeam Inc
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Heartbeam Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Heartbeam Inc
NASDAQ:BEAT
Total Current Assets
$4.7m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Total Current Assets
$8.8B
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Total Current Assets
$6.7B
CAGR 3-Years
30%
CAGR 5-Years
17%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Total Current Assets
$14.8B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Total Current Assets
$26B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Assets
$9.8B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
16%
No Stocks Found

Heartbeam Inc
Glance View

Market Cap
37.6m USD
Industry
Health Care

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 5 full-time employees. The company went IPO on 2021-10-14. The company specializes in cardiovascular diagnostic technology. The company is primarily focused on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company focuses on providing diagnostic data to help physicians with care management of patients with cardiovascular disease. The company delivers remote diagnostic and monitoring technologies that can be used for patients anywhere for ambulatory and emergency room (ER) use. Its telehealth product is comprised of a credit card-sized Electrocardiogram (ECG) machine and a cloud-based diagnostic software system. The company is applying its platform technology to create a software tool for detecting heart attacks in the ED environment. This software tool is designed to enable emergency physicians to diagnose heart attacks. Its credit card sized cardiac electrical signal collection device captures cardiac signals that represent projections of the heart vector.

BEAT Intrinsic Value
0.9985 USD
Undervaluation 8%
Intrinsic Value
Price $0.9158

See Also

What is Heartbeam Inc's Total Current Assets?
Total Current Assets
4.7m USD

Based on the financial report for Dec 31, 2025, Heartbeam Inc's Total Current Assets amounts to 4.7m USD.

What is Heartbeam Inc's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
5%

Over the last year, the Total Current Assets growth was 69%. The average annual Total Current Assets growth rates for Heartbeam Inc have been 5% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett